Fibroblast Protein GNL3 Emerges as Hidden Culprit in Chemotherapy Heart Damage
New research in mice shows that the nucleolar protein GNL3, produced by cardiac fibroblasts, worsens doxorubicin-induced heart injury by driving ...
New research in mice shows that the nucleolar protein GNL3, produced by cardiac fibroblasts, worsens doxorubicin-induced heart injury by driving ...
Stanford researchers have published a protocol for a high-throughput stem cell-based screening platform that identifies potential antifibrotic compounds for cardiac ...
An open-source Python package called ParTIpy scales archetypal analysis and Pareto task inference to millions of single cells, offering a ...
Deleting the RNA splicing factor PTBP1 in cardiac fibroblasts reshapes the profibrotic response by altering alternative splicing of key fibrosis-related ...
A new review proposes a staged, evidence-bound framework combining patient-specific iPSCs, atrial microphysiological systems and nanomedicine to model and potentially ...
Heart failure with preserved ejection fraction, or HFpEF, has become one of cardiology’s most difficult challenges. Patients retain a seemingly ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine